Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation
- 17 December 2019
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (3) , 326-331
Abstract
Febuxostat (FBX) is used to treat gout and chronic hyperuricemia. However, its bioavailability is moderate (49%) as a result of low solubility and first pass metabolism. Therefore, the aim of our study is to improve FBX bioavailability by enhancement its solubility using self-nanoemulsifying drug delivery system (SNEDDS) technique in the form of transdermal film to avoid hepatic metabolism. To accomplish this goal, Eight SNEDDS formulae were prepared according to a three-factor, two level D-Optimal mixture design to evaluate the effect of different ratios of the Lemon oil (X1), the surfactant Tween-20 (X2), and the co-surfactant PEG-400 (X3) on the globule size in order to reach smallest globular size. Results revealed that SNEDDS globule size ranged from 177 to 454 nm. The optimized formula consisted of 20% oil, 40% surfactant and 40% co-surfactant. Diffusion study showed improved enhancement in skin permeation that was confirmed by imaging using fluorescence microscope. In vivo plasma data showed significant (p< 0-05) difference in FBX plasma levels and pharmacokinetic parameters when compared with raw FBX loaded film. In conclusion, FBX-SNEDDS loaded transdermal film could be a successful way to improve solubility and skin permeability that would lead to improvement in patient's compliance.Keywords
This publication has 33 references indexed in Scilit:
- Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studiesInternational Journal of Nanomedicine, 2018
- In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performanceInternational Journal of Nanomedicine, 2018
- Development of a fluvastatin-loaded self-nanoemulsifying system to maximize therapeutic efficacy in human colorectal carcinoma cellsJournal of Drug Delivery Science and Technology, 2018
- Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluationDrug Design, Development and Therapy, 2016
- Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum CorneumPharmaceutics, 2015
- Optimization of self-nanoemulsifying systems for the enhancement ofin vivohypoglycemic efficacy of glimepiride transdermal patchesExpert Opinion on Drug Delivery, 2014
- Design and Optimization of Self-Nanoemulsifying Delivery System to Enhance Quercetin Hepatoprotective Activity in Paracetamol-Induced HepatotoxicityJournal of Pharmaceutical Sciences, 2014
- Approaches for breaking the barriers of drug permeation through transdermal drug deliveryJournal of Controlled Release, 2012
- SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimizationInternational Journal of Pharmaceutics, 2010
- A novel transdermal patch incorporating meloxicam: In vitro and in vivo characterizationInternational Journal of Pharmaceutics, 2010